226 related articles for article (PubMed ID: 37924005)
1. Alterations in gut microbiota and host transcriptome of patients with coronary artery disease.
Chen L; Mou X; Li J; Li M; Ye C; Gao X; Liu X; Ma Y; Xu Y; Zhong Y
BMC Microbiol; 2023 Nov; 23(1):320. PubMed ID: 37924005
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the gut microbiome and metabolism with coronary artery disease severity.
Liu H; Chen X; Hu X; Niu H; Tian R; Wang H; Pang H; Jiang L; Qiu B; Chen X; Zhang Y; Ma Y; Tang S; Li H; Feng S; Zhang S; Zhang C
Microbiome; 2019 Apr; 7(1):68. PubMed ID: 31027508
[TBL] [Abstract][Full Text] [Related]
3. Diversified Shifts in the Cross Talk between Members of the Gut Microbiota and Development of Coronary Artery Diseases.
Zhang T; Ren H; Du Z; Zou T; Guang X; Zhang Y; Tian Y; Zhu L; Yu J; Yu X; Zhang Z; Dai H
Microbiol Spectr; 2022 Dec; 10(6):e0280422. PubMed ID: 36301099
[TBL] [Abstract][Full Text] [Related]
4. Dysbiosis signatures of gut microbiota in coronary artery disease.
Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H
Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma.
Huang H; Ren Z; Gao X; Hu X; Zhou Y; Jiang J; Lu H; Yin S; Ji J; Zhou L; Zheng S
Genome Med; 2020 Nov; 12(1):102. PubMed ID: 33225985
[TBL] [Abstract][Full Text] [Related]
6. Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease.
Emoto T; Yamashita T; Kobayashi T; Sasaki N; Hirota Y; Hayashi T; So A; Kasahara K; Yodoi K; Matsumoto T; Mizoguchi T; Ogawa W; Hirata KI
Heart Vessels; 2017 Jan; 32(1):39-46. PubMed ID: 27125213
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction patients different from stable coronary artery disease.
Dong C; Yang Y; Wang Y; Hu X; Wang Q; Gao F; Sun S; Liu Q; Li L; Liu J; Tang Y; Zhang S; Wu C; Zhu H
J Adv Res; 2023 Apr; 46():101-112. PubMed ID: 35750287
[TBL] [Abstract][Full Text] [Related]
8. Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease.
Yoshida N; Sasaki K; Sasaki D; Yamashita T; Fukuda H; Hayashi T; Tabata T; Osawa R; Hirata KI; Kondo A
J Atheroscler Thromb; 2019 Aug; 26(8):705-719. PubMed ID: 30587666
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota from coronary artery disease patients contributes to vascular dysfunction in mice by regulating bile acid metabolism and immune activation.
Liu H; Tian R; Wang H; Feng S; Li H; Xiao Y; Luan X; Zhang Z; Shi N; Niu H; Zhang S
J Transl Med; 2020 Oct; 18(1):382. PubMed ID: 33036625
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiome-Based Diagnostic Model to Predict Coronary Artery Disease.
Zheng YY; Wu TT; Liu ZQ; Li A; Guo QQ; Ma YY; Zhang ZL; Xun YL; Zhang JC; Wang WR; Kadir P; Wang DY; Ma YT; Zhang JY; Xie X
J Agric Food Chem; 2020 Mar; 68(11):3548-3557. PubMed ID: 32100534
[TBL] [Abstract][Full Text] [Related]
11. Alterations of Gut Microbiome and Serum Metabolome in Coronary Artery Disease Patients Complicated With Non-alcoholic Fatty Liver Disease Are Associated With Adverse Cardiovascular Outcomes.
Hu X; Zhou R; Li H; Zhao X; Sun Y; Fan Y; Zhang S
Front Cardiovasc Med; 2021; 8():805812. PubMed ID: 35047580
[No Abstract] [Full Text] [Related]
12. The Effects of Moderate Alcohol Consumption on Circulating Metabolites and Gut Microbiota in Patients With Coronary Artery Disease.
Zhao X; Zhou R; Li H; Fan Y; Sun Y; Hu X; Zhang S
Front Cardiovasc Med; 2021; 8():767692. PubMed ID: 34796220
[No Abstract] [Full Text] [Related]
13. Analysis of Gut Microbiota in Coronary Artery Disease Patients: a Possible Link between Gut Microbiota and Coronary Artery Disease.
Emoto T; Yamashita T; Sasaki N; Hirota Y; Hayashi T; So A; Kasahara K; Yodoi K; Matsumoto T; Mizoguchi T; Ogawa W; Hirata K
J Atheroscler Thromb; 2016 Aug; 23(8):908-21. PubMed ID: 26947598
[TBL] [Abstract][Full Text] [Related]
14. Identification of circular RNA Hsa_circ_0001879 and Hsa_circ_0004104 as novel biomarkers for coronary artery disease.
Wang L; Shen C; Wang Y; Zou T; Zhu H; Lu X; Li L; Yang B; Chen J; Chen S; Lu X; Gu D
Atherosclerosis; 2019 Jul; 286():88-96. PubMed ID: 31103880
[TBL] [Abstract][Full Text] [Related]
15. Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis.
Yoshida N; Emoto T; Yamashita T; Watanabe H; Hayashi T; Tabata T; Hoshi N; Hatano N; Ozawa G; Sasaki N; Mizoguchi T; Amin HZ; Hirota Y; Ogawa W; Yamada T; Hirata KI
Circulation; 2018 Nov; 138(22):2486-2498. PubMed ID: 30571343
[TBL] [Abstract][Full Text] [Related]
16. Novel Inter-omic Analysis Reveals Relationships Between Diverse Gut Microbiota and Host Immune Dysregulation in HLA-B27-Induced Experimental Spondyloarthritis.
Gill T; Brooks SR; Rosenbaum JT; Asquith M; Colbert RA
Arthritis Rheumatol; 2019 Nov; 71(11):1849-1857. PubMed ID: 31216122
[TBL] [Abstract][Full Text] [Related]
17. Faecalibacterium prausnitzii as a potential Antiatherosclerotic microbe.
Yang HT; Jiang ZH; Yang Y; Wu TT; Zheng YY; Ma YT; Xie X
Cell Commun Signal; 2024 Jan; 22(1):54. PubMed ID: 38243314
[TBL] [Abstract][Full Text] [Related]
18. The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions.
Trøseid M; Andersen GØ; Broch K; Hov JR
EBioMedicine; 2020 Feb; 52():102649. PubMed ID: 32062353
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential M2 macrophage-associated diagnostic biomarkers in coronary artery disease.
Li K; Kong R; Ma L; Cao Y; Li W; Chen R; Gong K; Jiang L
Biosci Rep; 2022 Dec; 42(12):. PubMed ID: 36222281
[TBL] [Abstract][Full Text] [Related]
20. Adjusting for age improves identification of gut microbiome alterations in multiple diseases.
Ghosh TS; Das M; Jeffery IB; O'Toole PW
Elife; 2020 Mar; 9():. PubMed ID: 32159510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
